Digital Health
Understand the basic concepts of the new technologies and innovation solutions for health care products and services, what it is, and why it is so important.
Digital Health will give you an overview over digital tools for optimizing patient outcomes, how real-world data is valuable and effective as well as adds value overall for you as a medical expert in the modern world.
Digital health covers a wide range of health care products and services such as health and medical websites and platforms; decision algorithms, personal health apps, telemedicine and telehealth. Digital health technology ranges from simple scheduling tools to digital interventions that can potentially replace pharmaceuticals, diagnostics, as well as a variety of health care interventions.
A health care measurement solution based on digital assistance
Digital health technology introduces new and innovative solutions for health care at the same time optimizing patient outcomes. It provides the possibility for patients to gain more control over their treatment and become more sovereign in handling their own unique health care situation. Digital tools can change the patient pathways, the choice of interventions and the relationship between the actors in a treatment situation.
Patients play a central role due to improvements in self-monitoring and self-care made possible by real world data and new digital solutions. This situation requires new endpoints for measuring value, in order to demonstrate value to regulators, health care providers, patients and payers.
The course will address the following:
- Introduction to Digital Health Care
- Digital health practices – examples from the real world
- Stakeholders, new players and new business models
- Possibilities for collaboration between Big Tech, decision makers, practitioners and patients
- Impact on patient relevant outcomes
- Ethical concerns and transparency issues
- The regulatory environment for digital tools
- How digital tools are reimbursed by the public health care system
- Big data and what it means for the future of healthcare
- How covid-19 is changing the trajectory for digital health
This is an intensive 5-day course. Teaching methods consist of a combination of lectures, group discussions, case studies, presentations, simulation exercises and panel discussions.
You will receive continuous feedback during the course.
During the course, you will acquire a basic vocabulary and understanding of digital health issues and solutions. Upon completion of the course, you will:
- Understand the key steps in developing and implementing digital health solutions
- Identify the key stakeholders, their interests and motivations
- Discuss and evaluate rationales for and consequences of digital health solutions
- Identify, evaluate and discuss ethical concerns and transparency issues of digital health
- Critically reflect upon digital health proposals and practices
- Communicate specific issues and proposals for digital health with other specialists and stakeholders
- Collaborate within a multi-disciplinary digital health project team
Professionals in need of interdisciplinary overview
This course is intended for people who work in healthcare, public health, the pharmaceutical, device and diagnostics industry or the public sector. For example, managers and providers in the health care sector, employees from the pharmaceutical, diagnostic, and device industry, researchers at universities or research institutions, as well as politicians at local and national level.
Participants must
- Hold a relevant bachelor degree or equivalent
- Have a minimum 2 years of relevant job experience in drug development
- Be proficient in English
Find detailed information about the admission criteria.
Janine Marie Traulsen, External lecturer, Department of Pharmacy, University of Copenhagen.
Natalja Genina, Assoc. professor, Department of Pharmacy, University of Copenhagen
This course is offered as an elective course in Master of Industrial Drug Development and in Master of Medicines Regulatory Affairs.
Priority is given to students enrolled on Master of Industrial Drug Development and Master of Medicines Regulatory Affairs. Once the enrolled students have been admitted to the course, the remaining seats are distributed on a first-come, first-served basis.
Course capacity: 25 persons
Course details
| Duration: | 5 days on campus |
| Dates: | 12-16 August 2024 |
| Language: | English |
| Place: | University of Copenhagen, Copenhagen, Denmark |
| Course fee: |
23,000 DKK
Fee includes teaching, course materials, all meals during course hours and examination.
Payment conditions |
| Level and credit: | Master course; 3 ECTS |
| Examination date: | Please consult the exam schedule |
| Application deadline: | 31 May 2024 |
| Admission: | To be admitted, you must meet the admission criteria for Master of Industrial Drug Development |
Course dates and application deadlines are announced via the programme newsletter.
Download course curriculum